Ginkgo Bioworks Holdings annual return on equity
2020
2021
2022
2023
2024
2025
Ginkgo Bioworks Holdings Return on Equity (ROE) Growth & History (DNA)
Ginkgo Bioworks Holdings's return on equity was −51.08% for fiscal 2025.
View full Ginkgo Bioworks Holdings company overviewGinkgo Bioworks Holdings annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −51.08% | +9.26 pp |
| 2024 | 2024-12-31 | −60.34% | +2.69 pp |
| 2023 | 2023-12-31 | −63.02% | +66.84 pp |
| 2022 | 2022-12-31 | −129.87% | +113.27 pp |
| 2021 | 2021-12-31 | −243.13% | −192.68 pp |
| 2020 | 2020-12-31 | −50.45% | — |
Ginkgo Bioworks Holdings quarterly return on equity
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −10.82% | −1.25 pp |
| Q1 2026 | 2026-03-31 | −17.35% | −4.01 pp |
| Q4 2025 | 2025-12-31 | −15.12% | −0.91 pp |
| Q3 2025 | 2025-09-30 | −13.77% | −6.86 pp |
| Q2 2025 | 2025-06-30 | −9.57% | +14.29 pp |
| Q1 2025 | 2025-03-31 | −13.34% | +2.58 pp |
| Q4 2024 | 2024-12-31 | −14.21% | +3.81 pp |
| Q3 2024 | 2024-09-30 | −6.92% | +15.06 pp |
| Q2 2024 | 2024-06-30 | −23.86% | −12.72 pp |
| Q1 2024 | 2024-03-31 | −15.92% | −3.66 pp |
| Q4 2023 | 2023-12-31 | −18.02% | −6.95 pp |
| Q3 2023 | 2023-09-30 | −21.98% | +23.15 pp |
| Q2 2023 | 2023-06-30 | −11.14% | +31.78 pp |
| Q1 2023 | 2023-03-31 | −12.26% | +26.01 pp |
| Q4 2022 | 2022-12-31 | −11.07% | +93.66 pp |
| Q3 2022 | 2022-09-30 | −45.12% | −32.03 pp |
| Q2 2022 | 2022-06-30 | −42.93% | +1035.89 pp |
| Q1 2022 | 2022-03-31 | −38.27% | +2892.77 pp |
| Q4 2021 | 2021-12-31 | −104.72% | — |
| Q3 2021 | 2021-09-30 | −13.09% | — |
| Q2 2021 | 2021-06-30 | −1,078.82% | — |
| Q1 2021 | 2021-03-31 | −2,931.03% | — |
Ginkgo Bioworks Holdings return on equity trends
Over the last five fiscal years, Ginkgo Bioworks Holdings's return on equity decreased from −50.45% to −51.08%, a change of −0.62 percentage points. The latest reported quarter, Q2 2026, shows −10.82%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ginkgo Bioworks Holdings source filings ↗Community posts
Ginkgo joins a federally backed RNA-manufacturing project worth up to $17.5 million
Ginkgo Bioworks ($DNA) received a subcontract worth up to $17.5 million to participate in an ARPA-H program focused on RNA manufacturing. Waterfall Scientific is the prime contractor. The project, called ESCALATOR, is intended to combine co ...